DAVIS, Calif.Arcadia Biosciences, Inc., an agricultural biotechnology company, announced the commercial launch of SONOVA ULTRA GLA safflower oil. With 55 percent gamma linolenic acid (GLA), this addition to the company’s nutritional oils portfolio offers a GLA concentration more than twice as high as produced in any other commercial oilseed.
•GLA provides dietary support for a wide range of conditions such as weight management, skin health and women’s health (hormonal balance), with the core of its health benefits related to its anti-inflammatory attributes.
•GLA, in combination with the important omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) that are typically found in fish oil, has been shown to support heart and eye health and to reduce inflammation, asthma, diabetic neuropathy and rheumatoid arthritis.
•Current GLA research is focused on childhood and adolescent ADHD/ADD, adult diabetes and metabolic syndrome, inflammation and cardiovascular disease, atopic dermatitis and acne.
“Consumers seeking to maximize the benefits of functional ingredients are demanding increased efficacy with smaller doses," said Eric Rey, president and CEO of Arcadia. “SONOVA ULTRA features the most highly concentrated commercial source of GLA produced in a seed oil today, offering dietary supplement companies greater flexibility in the development of nutritional and functional food products."
SONOVA ULTRA GLA safflower oil and SONOVA 400 GLA safflower oil, which contains 40 percent GLA, are grown and produced in the United States under strict Identity Preservation (IP) protocols. SONOVA ULTRA GLA safflower oil currently available in bulk oil and softgels. Arcadia also offers retail-ready packaged softgels.